ctsnet Banner
 
 

Cardiothoracic Techniques and Technologies VII

 
 

SESSION VI:  The Cardiac Operating Room of the Future - Imaging Technology in the OR

 
     
 
 
 

ABSTRACT 54

Visualization of the Coronary Vasculature in the O.R.

Fraser Rubens1, Marc Ruel1, Marino Labinaz1, Mark Hynes1, Dario Del Rizzo2, University of Ottawa  Heart Institute1, Ottawa, Ontario, Canada, University of Manitoba2, Winnipeg, Manitoba, Canada.

Currently, there is no simple and effective method for validating the quality of a coronary artery bypass graft in the operating room. Here we report our initial experience with a novel technology for visualizing the coronary vasculature on the operating table at the time of a CABG procedure. This technique involves the acquisition of images of the coronary vasculature during the first pass of a bolus of a fluorescent contrast agent through the field of view.

Image acquisition entails positioning an imaging device, (Novadaq Technologies Inc), above the heart and injecting a bolus of an FDA approved fluorescent contrast agent into the right atrium. The imaging device emits light at 806 nm causing the contrast agent to fluoresce, emitting light at 830 nm, as it passes through the coronary vessels. The images of the vasculature are captured on a video camera, equipped with an 830 nm bandpass filter, and saved to video tape. The passage of contrast agent through the coronary vasculature can also be observed in real time on a video monitor.

Subjects were recruited from patients requiring primary, non-emergent coronary artery bypass surgery. Images of the coronary vasculature were acquired prior to starting the bypass procedure and also upon completion of the procedure, following weaning from bypass pump where appropriate.

Excellent image quality was achieved permitting visualization of coronary perfusion, nutrient perfusion and venous return over the entire left ventricle. This technique permits the rapid (2-3 min) acquisition of high quality images of the coronary vasculature under conditions appropriate to the assessment of graft quality at the time of CABG surgery.

This is the first use of this novel technology in humans, proving to be feasible and reproducible in the clinical setting and of particular note it was simple to use intra-operatively.

 
     
 
 
  [Program & Schedule] [Posters] [Contributors] [Faculty]  
     


CTSNet Search Feedback